tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APLT Stock Latest News

Applied Therapeutics Advances Govorestat Study for CMT-SORD
Company AnnouncementsApplied Therapeutics Advances Govorestat Study for CMT-SORD
13d ago
APLT
Applied Therapeutics completes FDA meeting on potential NDA for govorestat
PremiumThe Fly
Applied Therapeutics completes FDA meeting on potential NDA for govorestat
1M ago
APLT
Applied Therapeutics up after details posted for confirmatory govorestat study
PremiumThe Fly
Applied Therapeutics up after details posted for confirmatory govorestat study
1M ago
APLT
Applied Therapeutics Announces New Equity Offering Agreement
PremiumCompany Announcements
Applied Therapeutics Announces New Equity Offering Agreement
2M ago
8K
APLT
Strategic Positioning and Growth Potential: Joseph Schwartz’s Buy Rating on Applied Therapeutics
PremiumRatings
Strategic Positioning and Growth Potential: Joseph Schwartz’s Buy Rating on Applied Therapeutics
3M ago
APLT
Applied Therapeutics Granted Nasdaq Compliance Extension
PremiumCompany AnnouncementsApplied Therapeutics Granted Nasdaq Compliance Extension
3M ago
8K
APLT
Applied Therapeutics Advances Pipeline Amid Financial Challenges
Premium
Company Announcements
Applied Therapeutics Advances Pipeline Amid Financial Challenges
3M ago
APLT
Applied Therapeutics reports Q2 EPS (15c), consensus (16c)
Premium
The Fly
Applied Therapeutics reports Q2 EPS (15c), consensus (16c)
3M ago
APLT
Applied Therapeutics Faces Nasdaq Listing Challenge
PremiumCompany Announcements
Applied Therapeutics Faces Nasdaq Listing Challenge
3M ago
8K
APLT
Applied Therapeutics Announces New Chief Medical Officer
PremiumCompany Announcements
Applied Therapeutics Announces New Chief Medical Officer
5M ago
8K
APLT
Applied Therapeutics CMO Riccardo Perfetti to depart, Evan Bailey to succeed
PremiumThe Fly
Applied Therapeutics CMO Riccardo Perfetti to depart, Evan Bailey to succeed
5M ago
APLT
Applied Therapeutics Elects New Director at Annual Meeting
PremiumCompany Announcements
Applied Therapeutics Elects New Director at Annual Meeting
5M ago
8K
APLT
Hold Rating for Applied Therapeutics Amid Mixed Results from Govorestat Trial
PremiumRatingsHold Rating for Applied Therapeutics Amid Mixed Results from Govorestat Trial
6M ago
APLT
Applied announces INSPIRE Phase 2/3 trial primary endpoint not significant
Premium
The Fly
Applied announces INSPIRE Phase 2/3 trial primary endpoint not significant
6M ago
APLT
Strategic Advancements and Regulatory Progress Drive Buy Rating for Applied Therapeutics
Premium
Ratings
Strategic Advancements and Regulatory Progress Drive Buy Rating for Applied Therapeutics
6M ago
APLT
Applied Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Applied Therapeutics Reports Q1 2025 Financial Results
6M ago
APLT
Applied Therapeutics reports Q1 EPS (15c), consensus (18c)
PremiumThe Fly
Applied Therapeutics reports Q1 EPS (15c), consensus (18c)
6M ago
APLT
Applied Therapeutics to present full 12-month INSPIRE Phase 3 results
PremiumThe Fly
Applied Therapeutics to present full 12-month INSPIRE Phase 3 results
6M ago
APLT
Applied Therapeutics Reports 2024 Financial Results and Leadership Changes
PremiumCompany Announcements
Applied Therapeutics Reports 2024 Financial Results and Leadership Changes
7M ago
APLT
Applied Therapeutics reports FY24 EPS (76c), consensus ($1.33)
PremiumThe FlyApplied Therapeutics reports FY24 EPS (76c), consensus ($1.33)
7M ago
APLT
Applied Therapeutics Delays Yearly Report Filing
Premium
Company Announcements
Applied Therapeutics Delays Yearly Report Filing
7M ago
APLT
Applied Therapeutics files Form 12b-25 with SEC
Premium
The Fly
Applied Therapeutics files Form 12b-25 with SEC
7M ago
APLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >